PEDEvidence
Liraglutide research
Human

How did liraglutide perform in STEP 8?

6.4% weight reduction

Daily liraglutide 3 mg versus weekly semaglutide 2.4 mg.

Demonstrated findings

Mean weight reduction was 6.4%, versus 15.8% with semaglutide at 68 weeks.

Limitations & adverse findings

Treatment discontinuation for any reason: 27.6% versus 13.5% with semaglutide.

What might this mean? · interpretation

Liraglutide produced weight loss, with a smaller average change in this direct comparison.

What might this mean, and what would change the interpretation?

These results apply to the tested regimens in adults without diabetes.

What would clarify this: Comparisons of outcomes beyond body weight.

Findings reviewed · abstract

Checked Sep 15, 2026 against the linked abstract. This reading note is not a formal risk-of-bias appraisal.

Download evidence card

An editorial reading note with a primary-source link. Interpretation is identified separately from observed results.